RiskofNeverTakingHRT/Data: Difference between revisions
Risk of Never Taking HRT for Menopause / Data |
Risk of Never Taking HRT for Menopause / Data |
||
Line 1: | Line 1: | ||
= Data for RiskOfNeverTakingHRTForMenopause = | = Data for RiskOfNeverTakingHRTForMenopause = | ||
== Fracture Data == | == Fracture Risk Data == | ||
<datatable2 name="FractureRiskTable"> | <datatable2 name="FractureRiskTable"> | ||
<head> | <head> | ||
Fracture_Label | Fracture_WithHRT | Fracture_WithoutHRT | |||
</head> | </head> | ||
<row> | <row> | ||
7. | 7.1 years – estrogen-only HRT | 92–113 per 1000 | 141 per 1000 | ||
</row> | </row> | ||
<row> | <row> | ||
5. | 5.6 years – combined HRT | 79–96 per 1000 | 111 per 1000 | ||
</row> | </row> | ||
</datatable2> | </datatable2> | ||
*Explanation:* | *Explanation:* | ||
Women taking HRT had significantly lower fracture rates than those who did not, across both estrogen-only and combined regimens. | |||
- Source: [PubMed](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com) | - Source: [PubMed – WHI Analysis](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com) | ||
<RiskModel name="FractureRiskModel" calculation=" | <RiskModel name="FractureRiskModel" calculation="Fracture_WithoutHRT - Fracture_WithHRT"> | ||
Fracture_WithoutHRT = Fracture_WithoutHRT | |||
Fracture_WithHRT = Fracture_WithHRT | |||
</RiskModel> | </RiskModel> | ||
== Cardiovascular, Stroke, and VTE | == Cardiovascular, Stroke, and VTE Risk == | ||
<datatable2 name="CardiovascularRiskTable"> | <datatable2 name="CardiovascularRiskTable"> | ||
<head> | <head> | ||
Cardio_Label | Cardio_WithHRT | Cardio_WithoutHRT | |||
</head> | </head> | ||
<row> | <row> | ||
Line 40: | Line 40: | ||
*Explanation:* | *Explanation:* | ||
Combined HRT was associated with small increases in cardiovascular events. | |||
- Source: [CMAJ](https://www.cmaj.ca/content/170/10/1535?utm_source=chatgpt.com) | - Source: [CMAJ Review](https://www.cmaj.ca/content/170/10/1535?utm_source=chatgpt.com) | ||
<RiskModel name="CardiovascularRiskModel" calculation=" | <RiskModel name="CardiovascularRiskModel" calculation="Cardio_WithHRT - Cardio_WithoutHRT"> | ||
Cardio_WithHRT = Cardio_WithHRT[Coronary heart disease] | |||
Cardio_WithoutHRT = Cardio_WithoutHRT[Coronary heart disease] | |||
</RiskModel> | </RiskModel> | ||
<RiskModel name="StrokeRiskModel" calculation=" | <RiskModel name="StrokeRiskModel" calculation="Cardio_WithHRT - Cardio_WithoutHRT"> | ||
Cardio_WithHRT = Cardio_WithHRT[Stroke] | |||
Cardio_WithoutHRT = Cardio_WithoutHRT[Stroke] | |||
</RiskModel> | </RiskModel> | ||
<RiskModel name="VTERiskModel" calculation=" | <RiskModel name="VTERiskModel" calculation="Cardio_WithHRT - Cardio_WithoutHRT"> | ||
Cardio_WithHRT = Cardio_WithHRT[Venous thromboembolism (VTE)] | |||
Cardio_WithoutHRT = Cardio_WithoutHRT[Venous thromboembolism (VTE)] | |||
</RiskModel> | </RiskModel> | ||
Line 61: | Line 61: | ||
<datatable2 name="CancerRiskTable"> | <datatable2 name="CancerRiskTable"> | ||
<head> | <head> | ||
Cancer_Label | Cancer_WithHRT | Cancer_WithoutHRT | |||
</head> | </head> | ||
<row> | <row> | ||
Breast Cancer (combined | Breast Cancer (combined HRT) | +9 to +36 per 10,000 | baseline varies | ||
</row> | </row> | ||
<row> | <row> | ||
Ovarian Cancer | ~1 extra per 1,000 users | | Ovarian Cancer | ~1 extra per 1,000 users | baseline varies | ||
</row> | </row> | ||
<row> | <row> | ||
Endometrial Cancer | | Endometrial Cancer (combined HRT) | reduced or neutral | baseline varies | ||
</row> | </row> | ||
</datatable2> | </datatable2> | ||
*Explanation:* | *Explanation:* | ||
HRT | Breast and ovarian cancer risks are slightly increased with HRT use. Combined HRT may reduce endometrial cancer risk. | ||
- Sources: | - Sources: | ||
- [Menopause.org.au](https://www.menopause.org.au/members/ims-menopause-live/use-of-hormone-replacement-therapy-hrt-and-risk-of-breast-cancer?utm_source=chatgpt.com) | - [Menopause.org.au](https://www.menopause.org.au/members/ims-menopause-live/use-of-hormone-replacement-therapy-hrt-and-risk-of-breast-cancer?utm_source=chatgpt.com) | ||
- [SAGE | - [SAGE Review](https://journals.sagepub.com/doi/10.1177/2053369120957514?utm_source=chatgpt.com) | ||
<RiskModel name="BreastCancerRiskModel" calculation=" | <RiskModel name="BreastCancerRiskModel" calculation="Cancer_WithHRT"> | ||
Cancer_WithHRT = Cancer_WithHRT[Breast Cancer (combined HRT)] | |||
</RiskModel> | </RiskModel> | ||
<RiskModel name="OvarianCancerRiskModel" calculation=" | <RiskModel name="OvarianCancerRiskModel" calculation="Cancer_WithHRT"> | ||
Cancer_WithHRT = Cancer_WithHRT[Ovarian Cancer] | |||
</RiskModel> | </RiskModel> | ||
== Dementia | == Dementia Risk (Age ≥65) == | ||
<datatable2 name="DementiaRiskTable"> | <datatable2 name="DementiaRiskTable"> | ||
<head> | <head> | ||
Dementia_Label | Dementia_WithHRT | Dementia_WithoutHRT | |||
</head> | </head> | ||
<row> | <row> | ||
Women ≥65 using combined HRT | 11 per 1,000 | 9 per 1,000 | |||
</row> | </row> | ||
</datatable2> | </datatable2> | ||
*Explanation:* | *Explanation:* | ||
HRT started in older age (≥65) may slightly raise the risk of dementia. | |||
- Source: [PubMed](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com) | - Source: [WHI Memory Study – PubMed](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com) | ||
<RiskModel name="DementiaRiskModel" calculation="Dementia_WithHRT - Dementia_WithoutHRT"> | <RiskModel name="DementiaRiskModel" calculation="Dementia_WithHRT - Dementia_WithoutHRT"> | ||
Dementia_WithHRT = | Dementia_WithHRT = Dementia_WithHRT | ||
Dementia_WithoutHRT = | Dementia_WithoutHRT = Dementia_WithoutHRT | ||
</RiskModel> | </RiskModel> | ||
== Uncertainty Note == | == Uncertainty Note == | ||
Risk estimates are population-level averages and may vary based on age, timing of HRT, genetics, and other personal health factors. | |||
Generated by an AI assistant. | Generated by an AI assistant. |
Revision as of 00:19, 8 September 2025
Data for RiskOfNeverTakingHRTForMenopause
Fracture Risk Data
<datatable2 name="FractureRiskTable"> <head> Fracture_Label | Fracture_WithHRT | Fracture_WithoutHRT </head> <row> 7.1 years – estrogen-only HRT | 92–113 per 1000 | 141 per 1000 </row> <row> 5.6 years – combined HRT | 79–96 per 1000 | 111 per 1000 </row> </datatable2>
- Explanation:*
Women taking HRT had significantly lower fracture rates than those who did not, across both estrogen-only and combined regimens. - Source: [PubMed – WHI Analysis](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:FractureRiskModel Content: Fracture_WithoutHRT = Fracture_WithoutHRT Fracture_WithHRT = Fracture_WithHRT
Cardiovascular, Stroke, and VTE Risk
<datatable2 name="CardiovascularRiskTable"> <head> Cardio_Label | Cardio_WithHRT | Cardio_WithoutHRT </head> <row> Coronary heart disease | 157 per 10,000 | 132 per 10,000 </row> <row> Stroke | 44 per 10,000 | 32 per 10,000 </row> <row> Venous thromboembolism (VTE) | 34 per 10,000 | 16 per 10,000 </row> </datatable2>
- Explanation:*
Combined HRT was associated with small increases in cardiovascular events. - Source: [CMAJ Review](https://www.cmaj.ca/content/170/10/1535?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:CardiovascularRiskModel Content: Cardio_WithHRT = Cardio_WithHRT[Coronary heart disease] Cardio_WithoutHRT = Cardio_WithoutHRT[Coronary heart disease]
RiskModel: RiskofNeverTakingHRT/Data:StrokeRiskModel Content: Cardio_WithHRT = Cardio_WithHRT[Stroke] Cardio_WithoutHRT = Cardio_WithoutHRT[Stroke]
RiskModel: RiskofNeverTakingHRT/Data:VTERiskModel Content: Cardio_WithHRT = Cardio_WithHRT[Venous thromboembolism (VTE)] Cardio_WithoutHRT = Cardio_WithoutHRT[Venous thromboembolism (VTE)]
Cancer Risk Data
<datatable2 name="CancerRiskTable"> <head> Cancer_Label | Cancer_WithHRT | Cancer_WithoutHRT </head> <row> Breast Cancer (combined HRT) | +9 to +36 per 10,000 | baseline varies </row> <row> Ovarian Cancer | ~1 extra per 1,000 users | baseline varies </row> <row> Endometrial Cancer (combined HRT) | reduced or neutral | baseline varies </row> </datatable2>
- Explanation:*
Breast and ovarian cancer risks are slightly increased with HRT use. Combined HRT may reduce endometrial cancer risk. - Sources:
- [Menopause.org.au](https://www.menopause.org.au/members/ims-menopause-live/use-of-hormone-replacement-therapy-hrt-and-risk-of-breast-cancer?utm_source=chatgpt.com) - [SAGE Review](https://journals.sagepub.com/doi/10.1177/2053369120957514?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:BreastCancerRiskModel Content: Cancer_WithHRT = Cancer_WithHRT[Breast Cancer (combined HRT)]
RiskModel: RiskofNeverTakingHRT/Data:OvarianCancerRiskModel Content: Cancer_WithHRT = Cancer_WithHRT[Ovarian Cancer]
Dementia Risk (Age ≥65)
<datatable2 name="DementiaRiskTable"> <head> Dementia_Label | Dementia_WithHRT | Dementia_WithoutHRT </head> <row> Women ≥65 using combined HRT | 11 per 1,000 | 9 per 1,000 </row> </datatable2>
- Explanation:*
HRT started in older age (≥65) may slightly raise the risk of dementia. - Source: [WHI Memory Study – PubMed](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:DementiaRiskModel Content: Dementia_WithHRT = Dementia_WithHRT Dementia_WithoutHRT = Dementia_WithoutHRT
Uncertainty Note
Risk estimates are population-level averages and may vary based on age, timing of HRT, genetics, and other personal health factors.
Generated by an AI assistant.